<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2017" name="Monoamine Transport" organism="Homo sapiens" width="1730.0" height="1694.4041405197493">
  <Xref dataSource="" identifier="" />
  <Comment source="WikiPathways-category">Cellular Process</Comment>
  <DataNode elementID="b0705" textLabel="TSC2" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="1321.4833333333333" centerY="1432.9833333333333" width="75.03333333333333" height="40.03333333333333" zOrder="32768">
    <Comment>tuberous sclerosis 2</Comment>
    <Xref dataSource="Entrez Gene" identifier="7249" />
  </DataNode>
  <DataNode elementID="b270c" textLabel="SCAMP2" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="781.9833333333333" centerY="1513.4833333333333" width="70.03333333333333" height="37.03333333333333" zOrder="32768">
    <Comment>secretory carrier membrane protein 2</Comment>
    <Xref dataSource="Entrez Gene" identifier="10066" />
  </DataNode>
  <DataNode elementID="c3ea8" textLabel="RBL2" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="1466.4833333333333" centerY="1432.9833333333333" width="71.03333333333333" height="42.03333333333333" zOrder="32768">
    <Comment>retinoblastoma-like 2 (p130)</Comment>
    <Xref dataSource="Entrez Gene" identifier="5934" />
  </DataNode>
  <DataNode elementID="c5ac0" textLabel="AMPH" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="465.98333333333335" centerY="1440.9833333333333" width="70.03333333333333" height="38.03333333333333" zOrder="32768">
    <Comment>amphiphysin</Comment>
    <Xref dataSource="Entrez Gene" identifier="273" />
  </DataNode>
  <DataNode elementID="d30fb" textLabel="HEPES" type="Metabolite" color="00cc00" fontSize="10" vAlign="Middle" centerX="1414.9833333333333" centerY="465.48333333333335" width="68.03333333333333" height="27.033333333333335" zOrder="32768">
    <Xref dataSource="CAS" identifier="7365-45-9" />
  </DataNode>
  <DataNode elementID="dcd2c" textLabel="STX1A" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="678.9833333333333" centerY="1439.4833333333333" width="70.03333333333333" height="37.03333333333333" zOrder="32768">
    <Comment>syntaxin 1A (brain)</Comment>
    <Xref dataSource="Entrez Gene" identifier="6804" />
  </DataNode>
  <DataNode elementID="dffa1" textLabel="SYN1" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="550.9833333333333" centerY="1526.9833333333333" width="70.03333333333333" height="38.03333333333333" zOrder="32768">
    <Comment>synapsin I</Comment>
    <Xref dataSource="Entrez Gene" identifier="6853" />
  </DataNode>
  <DataNode elementID="efbe4" textLabel="reserpine" type="Metabolite" color="00cc00" fontSize="10" vAlign="Middle" centerX="402.2091397849463" centerY="909.9833333333333" width="70.03333333333333" height="36.03333333333333" zOrder="32770">
    <Xref dataSource="CAS" identifier="50-55-5" />
  </DataNode>
  <DataNode elementID="ed41e" textLabel="noradrenaline" type="Metabolite" color="00cc00" fontSize="10" vAlign="Middle" centerX="586.9833333333333" centerY="798.4833333333333" width="70.03333333333333" height="37.03333333333333" zOrder="32772">
    <Xref dataSource="CAS" identifier="51-41-2" />
  </DataNode>
  <DataNode elementID="da718" textLabel="anisomycin" type="Metabolite" color="009900" fontSize="10" vAlign="Middle" centerX="1278.9833333333333" centerY="841.4833333333333" width="68.03333333333333" height="33.03333333333333" zOrder="32774">
    <Xref dataSource="ChEBI" identifier="338412" />
  </DataNode>
  <DataNode elementID="d304b" textLabel="PVRL2" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="653.9833333333333" centerY="172.48333333333332" width="72.03333333333333" height="25.033333333333335" zOrder="32776">
    <Comment>poliovirus receptor-related 2 (herpesvirus entry mediator B)</Comment>
    <Xref dataSource="Entrez Gene" identifier="5819" />
  </DataNode>
  <DataNode elementID="f45dd" textLabel="TNF" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="1348.4833333333333" centerY="71.98333333333333" width="69.03333333333333" height="30.033333333333335" zOrder="32778">
    <Comment>tumor necrosis factor</Comment>
    <Xref dataSource="Entrez Gene" identifier="7124" />
  </DataNode>
  <DataNode elementID="aa11d" textLabel="SLC5A7" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="1494.9833333333333" centerY="254.98333333333332" width="72.03333333333333" height="34.03333333333333" zOrder="32780">
    <Comment>solute carrier family 5 (choline transporter), member 7</Comment>
    <Xref dataSource="Entrez Gene" identifier="60482" />
  </DataNode>
  <DataNode elementID="fa226" textLabel="FBXO32" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="1653.9833333333333" centerY="354.98333333333335" width="70.03333333333333" height="30.033333333333335" zOrder="32782">
    <Comment>F-box protein 32</Comment>
    <Xref dataSource="Entrez Gene" identifier="114907" />
  </DataNode>
  <DataNode elementID="f0d58" textLabel="SLC6A2" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="511.98333333333335" centerY="250.48333333333332" width="72.03333333333333" height="31.033333333333335" zOrder="32784">
    <Comment>solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2</Comment>
    <Xref dataSource="Entrez Gene" identifier="6530" />
  </DataNode>
  <DataNode elementID="e0a24" textLabel="ITGB3" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="1321.4833333333333" centerY="224.48333333333332" width="69.03333333333333" height="29.033333333333335" zOrder="32786">
    <Comment>integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)</Comment>
    <Xref dataSource="Entrez Gene" identifier="3690" />
  </DataNode>
  <DataNode elementID="fff2a" textLabel="SB 203580" type="Metabolite" color="009900" fontSize="10" vAlign="Middle" centerX="1279.9833333333333" centerY="978.4833333333333" width="68.03333333333333" height="31.033333333333335" zOrder="32788">
    <Xref dataSource="CAS" identifier="152121-47-6" />
  </DataNode>
  <DataNode elementID="fbe48" textLabel="CDC25C" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="1041.9833333333333" centerY="908.9833333333333" width="70.03333333333333" height="30.033333333333335" zOrder="32790">
    <Comment>cell division cycle 25 homolog C (S. pombe)</Comment>
    <Xref dataSource="Entrez Gene" identifier="995" />
  </DataNode>
  <DataNode elementID="d4621" textLabel="NOS1" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="1271.9833333333333" centerY="681.9833333333333" width="70.03333333333333" height="34.03333333333333" zOrder="32792">
    <Comment>nitric oxide synthase 1 (neuronal)</Comment>
    <Xref dataSource="Entrez Gene" identifier="4842" />
  </DataNode>
  <DataNode elementID="f3fbf" textLabel="ACHE" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="1636.9833333333333" centerY="897.4833333333333" width="70.03333333333333" height="33.03333333333333" zOrder="32794">
    <Comment>acetylcholinesterase (Yt blood group)</Comment>
    <Xref dataSource="Entrez Gene" identifier="43" />
  </DataNode>
  <DataNode elementID="a1d4c" textLabel="dopamine" type="Metabolite" color="00cc00" fontSize="10" vAlign="Middle" centerX="677.9833333333333" centerY="690.9833333333333" width="68.03333333333333" height="32.03333333333333" zOrder="32796">
    <Xref dataSource="CAS" identifier="51-61-6" />
  </DataNode>
  <DataNode elementID="c7403" textLabel="epinephrine" type="Metabolite" color="00cc00" fontSize="10" vAlign="Middle" centerX="590.4833333333333" centerY="1194.4833333333333" width="71.03333333333333" height="37.03333333333333" zOrder="32798">
    <Xref dataSource="CAS" identifier="51-43-4" />
  </DataNode>
  <DataNode elementID="af8e0" textLabel="DBH" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="484.48333333333335" centerY="987.4833333333333" width="69.03333333333333" height="35.03333333333333" zOrder="32800">
    <Comment>dopamine beta-hydroxylase (dopamine beta-monooxygenase)</Comment>
    <Xref dataSource="Entrez Gene" identifier="1621" />
  </DataNode>
  <DataNode elementID="e7ff2" textLabel="TDO2" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="975.9833333333333" centerY="718.9833333333333" width="70.03333333333333" height="36.03333333333333" zOrder="32802">
    <Comment>tryptophan 2,3-dioxygenase</Comment>
    <Xref dataSource="Entrez Gene" identifier="6999" />
  </DataNode>
  <DataNode elementID="dd5b5" textLabel="4-Aminobutanoic acid" type="Metabolite" color="00cc00" fontSize="10" vAlign="Middle" centerX="791.0" centerY="1125.9833333333333" width="112.0" height="36.03333333333333" zOrder="32804">
    <Xref dataSource="CAS" identifier="56-12-2" />
  </DataNode>
  <DataNode elementID="e4546" textLabel="TNFRSF11B" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="1210.4833333333333" centerY="231.98333333333332" width="73.03333333333333" height="32.03333333333333" zOrder="32806">
    <Comment>tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin)</Comment>
    <Xref dataSource="Entrez Gene" identifier="4982" />
  </DataNode>
  <DataNode elementID="d8b07" textLabel="catecholamines" type="Metabolite" color="00cc00" fontSize="10" vAlign="Middle" centerX="344.98333333333335" centerY="844.9833333333333" width="68.03333333333333" height="30.033333333333335" zOrder="32808">
    <Xref dataSource="ChEBI" identifier="33567" />
  </DataNode>
  <DataNode elementID="f01fc" textLabel="AGT" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="567.4833333333333" centerY="78.98333333333333" width="69.03333333333333" height="26.033333333333335" zOrder="32810">
    <Comment>angiotensinogen (serpin peptidase inhibitor, clade A, member 8)</Comment>
    <Xref dataSource="Entrez Gene" identifier="183" />
  </DataNode>
  <DataNode elementID="f6108" textLabel="SLC6A3" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="758.4833333333333" centerY="283.98333333333335" width="73.03333333333333" height="34.03333333333333" zOrder="32812">
    <Comment>solute carrier family 6 (neurotransmitter transporter, dopamine), member 3</Comment>
    <Xref dataSource="Entrez Gene" identifier="6531" />
  </DataNode>
  <DataNode elementID="d95ce" textLabel="serotonin" type="Metabolite" color="00cc00" fontSize="10" vAlign="Middle" centerX="1317.9833333333333" centerY="571.9833333333333" width="70.03333333333333" height="34.03333333333333" zOrder="32814">
    <Xref dataSource="CAS" identifier="50-67-9" />
  </DataNode>
  <DataNode elementID="a26a3" textLabel="TPH2" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="1434.4833333333333" centerY="758.4833333333333" width="69.03333333333333" height="35.03333333333333" zOrder="32816">
    <Comment>tryptophan hydroxylase 2</Comment>
    <Xref dataSource="Entrez Gene" identifier="121278" />
  </DataNode>
  <DataNode elementID="efefa" textLabel="Hemicholinium-3" type="Metabolite" color="00cc00" fontSize="10" vAlign="Middle" centerX="1546.9833333333333" centerY="832.4833333333333" width="70.03333333333333" height="37.03333333333333" zOrder="32818">
    <Xref dataSource="CAS" identifier="312-45-8" />
  </DataNode>
  <DataNode elementID="c42df" textLabel="HRH3" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="388.48333333333335" centerY="249.48333333333332" width="69.03333333333333" height="25.033333333333335" zOrder="32820">
    <Comment>histamine receptor H3</Comment>
    <Xref dataSource="Entrez Gene" identifier="11255" />
  </DataNode>
  <DataNode elementID="a34e2" textLabel="MAPK14" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="1071.9833333333333" centerY="720.4833333333333" width="70.03333333333333" height="37.03333333333333" zOrder="32822">
    <Comment>mitogen activated protein kinase 14</Comment>
    <Xref dataSource="Entrez Gene" identifier="1432" />
  </DataNode>
  <DataNode elementID="b593d" textLabel="TGFB1I1" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="879.9833333333333" centerY="356.98333333333335" width="52.03333333333333" height="32.03333333333333" zOrder="32824">
    <Comment>transforming growth factor beta 1 induced transcript 1</Comment>
    <Xref dataSource="Entrez Gene" identifier="7041" />
  </DataNode>
  <DataNode elementID="a5180" textLabel="Phorbol ester" type="Metabolite" color="00cc00" fontSize="10" vAlign="Middle" centerX="1228.9833333333333" centerY="364.0" width="70.03333333333333" height="30.0" zOrder="32826">
    <Xref dataSource="CAS" identifier="16561-29-8" />
  </DataNode>
  <DataNode elementID="f9dec" textLabel="SLC6A1" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="865.9833333333333" centerY="283.48333333333335" width="72.03333333333333" height="31.033333333333335" zOrder="32828">
    <Comment>solute carrier family 6 (neurotransmitter transporter, GABA), member 1</Comment>
    <Xref dataSource="Entrez Gene" identifier="6529" />
  </DataNode>
  <DataNode elementID="ac435" textLabel="IL1R1" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="1111.9833333333333" centerY="178.48333333333332" width="70.03333333333333" height="29.033333333333335" zOrder="32830">
    <Comment>interleukin 1 receptor, type I</Comment>
    <Xref dataSource="Entrez Gene" identifier="3554" />
  </DataNode>
  <DataNode elementID="d8f25" textLabel="citalopram" type="Metabolite" color="00cc00" fontSize="10" vAlign="Middle" centerX="923.4833333333333" centerY="507.48333333333335" width="59.03333333333333" height="29.033333333333335" zOrder="32834">
    <Xref dataSource="CAS" identifier="59729-33-8" />
  </DataNode>
  <DataNode elementID="d172d" textLabel="UNC13B" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="479.98333333333335" centerY="1081.9833333333333" width="70.03333333333333" height="38.03333333333333" zOrder="32836">
    <Comment>unc-13 homolog B (C. elegans)</Comment>
    <Xref dataSource="Entrez Gene" identifier="10497" />
  </DataNode>
  <DataNode elementID="a47e1" textLabel="L-tryptophan" type="Metabolite" color="00cc00" fontSize="10" vAlign="Middle" centerX="1100.9833333333333" centerY="510.98333333333335" width="68.03333333333333" height="28.033333333333335" zOrder="32838">
    <Xref dataSource="CAS" identifier="73-22-3" />
  </DataNode>
  <DataNode elementID="a12ed" textLabel="ADORA2A" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="1405.9833333333333" centerY="255.98333333333332" width="72.03333333333333" height="32.03333333333333" zOrder="32840">
    <Comment>adenosine A2a receptor</Comment>
    <Xref dataSource="Entrez Gene" identifier="135" />
  </DataNode>
  <DataNode elementID="d13b5" textLabel="TH" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="457.98333333333335" centerY="713.9833333333333" width="72.03333333333333" height="38.03333333333333" zOrder="32842">
    <Comment>tyrosine hydroxylase</Comment>
    <Xref dataSource="Entrez Gene" identifier="7054" />
  </DataNode>
  <DataNode elementID="ab696" textLabel="PPP2CB" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="949.9833333333333" centerY="621.4833333333333" width="54.03333333333333" height="35.03333333333333" zOrder="32844">
    <Comment>protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform</Comment>
    <Xref dataSource="Entrez Gene" identifier="5516" />
  </DataNode>
  <DataNode elementID="dfe0c" textLabel="IL1B" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="1211.4833333333333" centerY="82.98333333333333" width="69.03333333333333" height="30.033333333333335" zOrder="32846">
    <Comment>interleukin 1 beta</Comment>
    <Xref dataSource="Entrez Gene" identifier="3553" />
  </DataNode>
  <DataNode elementID="a1030" textLabel="SLC6A4" type="GeneProduct" color="cc0000" fontSize="10" vAlign="Middle" centerX="993.4833333333333" centerY="302.98333333333335" width="73.03333333333333" height="32.03333333333333" zOrder="32848">
    <Comment>solute carrier family 6 (neurotransmitter transporter, serotonin), member 4</Comment>
    <Xref dataSource="Entrez Gene" identifier="6532" />
  </DataNode>
  <Interaction elementID="a1137" zOrder="12288" lineStyle="Broken" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Regulation IL1B --+&gt; MAPK14
</Comment>
    <Comment>Western blots showed that IL-1 b and TNFa activated p38 MAPK, in an SB203580-sensitive manner.</Comment>
    <CitationRef citationID="d77" />
    <Point elementID="ed410" elementRef="dfe0c" x="1211.4833333333333" y="98.0" relX="0.0" relY="1.0" />
    <Point elementID="c005e" elementRef="a34e2" arrowHead="mim-necessary-stimulation" x="1089.4916666666668" y="701.9666666666667" relX="0.5" relY="-1.0" />
  </Interaction>
  <Interaction elementID="a1577" zOrder="12288" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Mol Transport SLC6A2 ---&gt; noradrenaline</Comment>
    <Comment>12805287 
The norepinephrine transporter (NET) mediates reuptake of norepinephrine released from neurons, and, as such, it is an importantregulator of noradrenergic neurotransmission. 

14566944 
It will be important in future studies to determine the exactconditions under which cytoplasmic NET is mobilized tothe plasma membrane of PFC NE axons.</Comment>
    <CitationRef citationID="a55" />
    <CitationRef citationID="b83" />
    <Point elementID="afc15" elementRef="ed41e" arrowHead="Arrow" x="586.9833333333333" y="779.9666666666667" relX="0.0" relY="-1.0" />
    <Point elementID="cf405" elementRef="f0d58" x="511.98333333333335" y="266.0" relX="0.0" relY="1.0" />
  </Interaction>
  <Interaction elementID="a3536" zOrder="12288" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Mol Transport STX1A ---&gt; 4-Aminobutanoic acid
</Comment>
    <Comment>Wang D, Deken SL, Whitworth TL, and Quick MW (2003) Syntaxin 1A inhibits GABA flux, efflux, and exchange mediated by the rat brain GABA transporter GAT1. </Comment>
    <CitationRef citationID="b9f" />
    <Point elementID="d0a02" elementRef="dcd2c" x="696.4916666666667" y="1420.9666666666667" relX="0.5" relY="-1.0" />
    <Point elementID="ddc2d" elementRef="dd5b5" arrowHead="Arrow" x="791.0" y="1144.0" relX="0.0" relY="1.0" />
  </Interaction>
  <Interaction elementID="a38f6" zOrder="12288" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Mol Transport SLC6A3 ---&gt; dopamine</Comment>
    <Comment>18614672
Interestingly,a study examining engineered proline-to-alanine substitutions inTM12 of the rat DAT documented an increased V max for DA efflux (Itokawa et al., 2002). </Comment>
    <CitationRef citationID="fc1" />
    <Point elementID="a6819" elementRef="f6108" x="758.4833333333333" y="301.0" relX="0.0" relY="1.0" />
    <Point elementID="cdc12" elementRef="a1d4c" arrowHead="Arrow" x="694.9916666666667" y="674.9666666666667" relX="0.5" relY="-1.0" />
  </Interaction>
  <Interaction elementID="a39de" zOrder="12288" lineStyle="Broken" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Regulation anisomycin --+&gt; MAPK14
</Comment>
    <Comment>Anisomycin, a protein synthesis inhibitor derived from Streptomyces griseolus , has been shown to trigger p38 MAPK phosphorylation in a variety of cells, including neutro-phils (55), mast cells (37), and myocardial cells (56). </Comment>
    <CitationRef citationID="ead" />
    <Point elementID="b13ad" elementRef="da718" x="1278.9833333333333" y="824.9666666666667" relX="0.0" relY="-1.0" />
    <Point elementID="ebb1b" elementRef="a34e2" arrowHead="mim-necessary-stimulation" x="1089.4916666666668" y="739.0" relX="0.5" relY="1.0" />
  </Interaction>
  <Interaction elementID="a3f40" zOrder="12288" lineThickness="1.0" color="0000cc">
    <Xref dataSource="" identifier="" />
    <Comment>Expression AMPH ---| SLC6A3</Comment>
    <Comment>17032905 
In heterologous expression systems and in ex vivo preparations, AMPH exposure diminishes plasma membrane expression of DAT proteins (Saunders et al., 2000; Gulley et al., 2002; Chi and Reith, 2003). </Comment>
    <CitationRef citationID="b9f" />
    <Point elementID="c9a9a" elementRef="c5ac0" x="465.98333333333335" y="1421.9666666666667" relX="0.0" relY="-1.0" />
    <Point elementID="b2ba3" elementRef="f6108" arrowHead="mim-inhibition" x="740.225" y="301.0" relX="-0.5" relY="1.0" />
  </Interaction>
  <Interaction elementID="a4655" zOrder="12288" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Regulation HEPES ---| SLC6A4
</Comment>
    <Comment>Ming L, Farley RA, Lester HA (2002) Voltage-dependent transient currents of human and rat 5-HT transporters (SERT) are blocked by HEPES and ion channel ligands. </Comment>
    <CitationRef citationID="a69" />
    <Point elementID="c0740" elementRef="d30fb" x="1397.975" y="451.9666666666667" relX="-0.5" relY="-1.0" />
    <Point elementID="ff401" elementRef="a1030" arrowHead="TBar" x="1011.7416666666667" y="319.0" relX="0.5" relY="1.0" />
  </Interaction>
  <Interaction elementID="a6b91" zOrder="12288" lineThickness="1.0" color="990099">
    <Xref dataSource="" identifier="" />
    <Comment>Binding SLC6A4 ---- SYN1</Comment>
    <Comment>18445122 
Possibly, asSung et al. have proposed for NET, Syn1A associations with SERT dictate whether the transporter contributes to membrane excitability and/or whether the transporterenters a higher capacity 5-HT transport mode (Figure 3). </Comment>
    <CitationRef citationID="bde" />
    <Point elementID="a6380" elementRef="dffa1" x="568.4916666666667" y="1507.9666666666667" relX="0.5" relY="-1.0" />
    <Point elementID="a3c29" elementRef="a1030" x="956.9666666666667" y="310.9916666666667" relX="-1.0" relY="0.5" />
  </Interaction>
  <Interaction elementID="aad5a" zOrder="12288" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Regulation IL1R1 ---| IL1B</Comment>
    <Comment>IL-1ra (10 ng/ ml) completely blocked IL-1 b but not anisomycin-induced 5-HT uptake in both (a) midbrain and (b) striatum. </Comment>
    <CitationRef citationID="d77" />
    <Point elementID="e4bdd" elementRef="ac435" x="1111.9833333333333" y="163.96666666666664" relX="0.0" relY="-1.0" />
    <Point elementID="e4bc8" elementRef="dfe0c" arrowHead="TBar" x="1194.225" y="98.0" relX="-0.5" relY="1.0" />
  </Interaction>
  <Interaction elementID="aae6f" zOrder="12288" lineThickness="1.0" color="0000ff">
    <Xref dataSource="" identifier="" />
    <Comment>Expression AGT --+&gt; SLC6A2</Comment>
    <Comment>14697674
Angiotensin II increases surface NET expression on brainstem neurons in vitro.

15963952
Depolarization and angiotensin II rapidly increase surface NET expression in primary brainstemcultures [19,20] .</Comment>
    <CitationRef citationID="cbf" />
    <CitationRef citationID="a0b" />
    <Point elementID="a1906" elementRef="f01fc" x="567.4833333333333" y="92.0" relX="0.0" relY="1.0" />
    <Point elementID="cd244" elementRef="f0d58" arrowHead="mim-necessary-stimulation" x="511.98333333333335" y="234.96666666666664" relX="0.0" relY="-1.0" />
  </Interaction>
  <Interaction elementID="ac654" zOrder="12288" lineThickness="1.0" color="009999">
    <Xref dataSource="" identifier="" />
    <Comment>Mol Synthesis TH ---&gt; catecholamines
</Comment>
    <Comment>These observations have always been difficult to understand, given that TH is readily detected in LC cell bodies (Pickel et al., 1975b) and that catecholamine synthesis requires TH.</Comment>
    <CitationRef citationID="a35" />
    <Point elementID="ca2e3" elementRef="d13b5" x="439.975" y="733.0" relX="-0.5" relY="1.0" />
    <Point elementID="f0f45" elementRef="d8b07" arrowHead="Arrow" x="344.98333333333335" y="829.9666666666667" relX="0.0" relY="-1.0" />
  </Interaction>
  <Interaction elementID="aee10" zOrder="12288" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Mol Transport ADORA2A ---&gt; serotonin
</Comment>
    <Comment>Mirtazapine is a 2 -receptor antagonist that increases presynaptic release of both serotonin and norepinephrine (de Boer 1996) and is also a 5HT 2 and 5HT 3 antagonist. </Comment>
    <CitationRef citationID="c58" />
    <Point elementID="bccec" elementRef="a12ed" x="1405.9833333333333" y="272.0" relX="0.0" relY="1.0" />
    <Point elementID="a4d18" elementRef="d95ce" arrowHead="Arrow" x="1335.4916666666668" y="554.9666666666667" relX="0.5" relY="-1.0" />
  </Interaction>
  <Interaction elementID="af884" zOrder="12288" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Mol Transport ITGB3 ---&gt; serotonin
</Comment>
    <Comment>Remark ably, homozygous disruption of Itgb3 led to an approximately 70% decrease in 5-HT uptake (2-tailed, unpaired Student&amp;apos;s t test, P &lt; 0.05, n = 5; Figure 2C). </Comment>
    <CitationRef citationID="d45" />
    <Point elementID="eeb6f" elementRef="e0a24" x="1321.4833333333333" y="238.99999999999994" relX="0.0" relY="1.0" />
    <Point elementID="fe6e9" elementRef="d95ce" arrowHead="Arrow" x="1317.9833333333333" y="554.9666666666667" relX="0.0" relY="-1.0" />
  </Interaction>
  <Interaction elementID="aff0c" zOrder="12288" lineStyle="Broken" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Regulation SLC6A4 ---| MAPK14
</Comment>
    <Comment>16803896 
Recent reportsalso show that cell surface levels of SERT can be modified byprotein kinase G (PKG) activation and p38 MAPK inactivation(36). </Comment>
    <CitationRef citationID="a8f" />
    <Point elementID="c45ca" elementRef="a1030" x="993.4833333333333" y="319.0" relX="0.0" relY="1.0" />
    <Point elementID="f65e8" elementRef="a34e2" arrowHead="TBar" x="1071.9833333333333" y="701.9666666666667" relX="0.0" relY="-1.0" />
  </Interaction>
  <Interaction elementID="b55ce" zOrder="12288" lineStyle="Broken" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Regulation Phorbol ester --+&gt; SLC6A4
</Comment>
    <Comment>External 5HT can suppress phorbol ester-induced SERT phosphorylation and internalization, providinga mechanism to tune SERT capacity to the demands of 5HTrelease (34).</Comment>
    <CitationRef citationID="a8f" />
    <Point elementID="fbff6" elementRef="a5180" x="1211.475" y="349.0" relX="-0.5" relY="-1.0" />
    <Point elementID="a6b64" elementRef="a1030" arrowHead="mim-necessary-stimulation" x="1030.0" y="294.975" relX="1.0" relY="-0.5" />
  </Interaction>
  <Interaction elementID="b5962" zOrder="12288" lineStyle="Broken" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Regulation reserpine --+&gt; DBH
</Comment>
    <Comment>Reserpine selectively increases tyrosine hydroxylase and dopaminebeta-hydroxylase enzyme protein in central noradrenergic neurons. </Comment>
    <CitationRef citationID="b83" />
    <Point elementID="ffcea" elementRef="efbe4" x="402.2091397849463" y="928.0" relX="0.0" relY="1.0" />
    <Point elementID="bca03" elementRef="af8e0" arrowHead="mim-necessary-stimulation" x="484.48333333333335" y="969.9666666666667" relX="0.0" relY="-1.0" />
  </Interaction>
  <Interaction elementID="b8a33" zOrder="12288" lineStyle="Broken" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Regulation TNF --+&gt; MAPK14
</Comment>
    <Comment>Western blots showed that IL-1 b and TNFa activated p38 MAPK, in an SB203580-sensitive manner. </Comment>
    <CitationRef citationID="d77" />
    <Point elementID="ddefb" elementRef="f45dd" x="1331.225" y="87.0" relX="-0.5" relY="1.0" />
    <Point elementID="b3c13" elementRef="a34e2" arrowHead="mim-necessary-stimulation" x="1107.0" y="720.4833333333333" relX="1.0" relY="0.0" />
  </Interaction>
  <Interaction elementID="bd521" zOrder="12288" lineThickness="1.0" color="0000ff">
    <Xref dataSource="" identifier="" />
    <Comment>Expression TH --+&gt; SLC6A2,</Comment>
    <Comment>16452680 (Tissue: cortex, CellType: neural, CellLineName: NE) If NET and TH localization are linked to activity states, then chronic stress should increase plasmalemmal NET and TH expression, thus altering the dynamics of NE transmission and impacting cognition and affect. 

</Comment>
    <CitationRef citationID="a35" />
    <Point elementID="a70b3" elementRef="d13b5" x="439.975" y="694.9666666666667" relX="-0.5" relY="-1.0" />
    <Point elementID="ae7a6" elementRef="f0d58" arrowHead="mim-necessary-stimulation" x="493.975" y="266.0" relX="-0.5" relY="1.0" />
  </Interaction>
  <Interaction elementID="c189d" zOrder="12288" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>MolTransport SLC6A4 ---&gt; L-tryptophan
</Comment>
    <Comment>Serotonin transporter polymorphism mediates vulnerability to loss of incentivemotivation following acute tryptophan depletion. </Comment>
    <CitationRef citationID="c84" />
    <Point elementID="c5850" elementRef="a1030" x="1030.0" y="310.9916666666667" relX="1.0" relY="0.5" />
    <Point elementID="e938c" elementRef="a47e1" arrowHead="Arrow" x="1100.9833333333333" y="496.9666666666667" relX="0.0" relY="-1.0" />
  </Interaction>
  <Interaction elementID="c2f60" zOrder="12288" lineThickness="1.0" color="009999">
    <Xref dataSource="" identifier="" />
    <Comment>MolSynthesis AMPH ---&gt; dopamine
</Comment>
    <Comment>Notably, when examined in rodents, BOLD responses to AMPH are linearly correlated with AMPHinduced changes in extracellular DA levels within thestriatum [54,55]. </Comment>
    <CitationRef citationID="e9b" />
    <Point elementID="b293d" elementRef="c5ac0" x="465.98333333333335" y="1421.9666666666667" relX="0.0" relY="-1.0" />
    <Point elementID="db35b" elementRef="a1d4c" arrowHead="Arrow" x="660.975" y="707.0" relX="-0.5" relY="1.0" />
  </Interaction>
  <Interaction elementID="c3827" zOrder="12288" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Mol Transport HRH3 ---&gt; noradrenaline</Comment>
    <Comment>12196911
Activation of histamine H3-receptors inhibits carrier-mediated norepinephrine release during protracted myocardial ischemia.

18674600
Hatta E, Yasuda K, Levi R (1997) Activation of histamine H 3 receptors inhibits carrier-mediated norepinephrine release in a human model of protracted myocardial ischemia.</Comment>
    <CitationRef citationID="ca9" />
    <CitationRef citationID="d51" />
    <Point elementID="c672d" elementRef="c42df" x="388.48333333333335" y="262.0" relX="0.0" relY="1.0" />
    <Point elementID="bc452" elementRef="ed41e" arrowHead="Arrow" x="569.475" y="779.9666666666667" relX="-0.5" relY="-1.0" />
  </Interaction>
  <Interaction elementID="c46bf" zOrder="12288" lineThickness="1.0" color="009999">
    <Xref dataSource="" identifier="" />
    <Comment>MolSynthesis anisomycin --+&gt; SB 203580
</Comment>
    <Comment>In the experiments shown, RBL-2H3 cellswere treated with vehicle, NECA, or anisomycin (0.5 and 1.0 M ) for 5 min in KRH assay buffer in the absence/presence of the p38 MAPK inhibitor, SB203580. </Comment>
    <CitationRef citationID="ead" />
    <Point elementID="a164e" elementRef="da718" x="1278.9833333333333" y="858.0" relX="0.0" relY="1.0" />
    <Point elementID="fb510" elementRef="fff2a" arrowHead="Arrow" x="1279.9833333333333" y="962.9666666666667" relX="0.0" relY="-1.0" />
  </Interaction>
  <Interaction elementID="c549c" zOrder="12288" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>MolTransport MAPK14 ---&gt; serotonin
</Comment>
    <Comment>15155839 
NECA treatments also lead to activation of p38 MAPK, and p38MAPK inhibitors block NECA stimulation of 5-HT uptake.

16055563 
Altered PKG p38 MAPK sensitivity of 56Ala is evident in native lymphocytes and may involve altered transporter phosphorylation. ( A ) Lymphocytes were genotyped and cultured as described in Materials and Methods and assessed for 5-HT uptake regulation as described for transfected HeLacells.</Comment>
    <CitationRef citationID="cb5" />
    <CitationRef citationID="d69" />
    <Point elementID="d9459" elementRef="a34e2" x="1107.0" y="729.7416666666667" relX="1.0" relY="0.5" />
    <Point elementID="cf66b" elementRef="d95ce" arrowHead="Arrow" x="1300.475" y="589.0" relX="-0.5" relY="1.0" />
  </Interaction>
  <Interaction elementID="c5c09" zOrder="12288" lineStyle="Broken" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Regulation MAPK14 ---&gt; SLC6A4
</Comment>
    <Comment>18317590 
Tonic activation p38 MAPK signal ing pathways, without direct phosphorylation of the transporter, controls basal surface SERT expression levels, whereas acute p38 MAPK activation induces trafficking-independent stimulation of SERT transport activity (12, 16). </Comment>
    <CitationRef citationID="d45" />
    <Point elementID="b40fd" elementRef="a34e2" x="1054.475" y="701.9666666666667" relX="-0.5" relY="-1.0" />
    <Point elementID="d56f8" elementRef="a1030" arrowHead="Arrow" x="993.4833333333333" y="319.0" relX="0.0" relY="1.0" />
  </Interaction>
  <Interaction elementID="c5d52" zOrder="12288" lineThickness="1.0" color="009999">
    <Xref dataSource="" identifier="" />
    <Comment>Mol Synthesis SLC6A2 ---&gt; dopamine</Comment>
    <Comment>15103690 
Given the ability of NET to transport DA (Horn, 1973; Raiteri et al., 1977; Gu et al., 1996), one probable mechanism by which NET inhibitors might increase DA levels is by blocking an important clearance mechanism for DA </Comment>
    <CitationRef citationID="d5e" />
    <Point elementID="a836e" elementRef="f0d58" x="529.9916666666667" y="266.0" relX="0.5" relY="1.0" />
    <Point elementID="b95a9" elementRef="a1d4c" arrowHead="Arrow" x="660.975" y="674.9666666666667" relX="-0.5" relY="-1.0" />
  </Interaction>
  <Interaction elementID="c828e" zOrder="12288" lineThickness="1.0" color="999900">
    <Xref dataSource="" identifier="" />
    <Comment>ProtModification MAPK14 ---&gt; TSC2
</Comment>
    <Comment>Phosphorylation of Cdc25 and tuberin by p38 MAPK enhances interac-tion of these proteins with 14-3-3 [58,59] .</Comment>
    <CitationRef citationID="ccb" />
    <Point elementID="a2f69" elementRef="a34e2" x="1071.9833333333333" y="739.0" relX="0.0" relY="1.0" />
    <Point elementID="c8aa7" elementRef="b0705" arrowHead="Arrow" x="1321.4833333333333" y="1412.9666666666667" relX="0.0" relY="-1.0" />
  </Interaction>
  <Interaction elementID="ca817" zOrder="12288" lineThickness="1.0" color="990099">
    <Xref dataSource="" identifier="" />
    <Comment>Binding SYN1 ---- UNC13B
</Comment>
    <Comment>In particular, Munc13 binds to SYN1A and is responsible for phorbol ester-mediated enhancements in neurotransmission ( Betz et al., 1998 ). </Comment>
    <CitationRef citationID="f47" />
    <Point elementID="e76b5" x="475.0" y="1094.0" />
    <Point elementID="bf4aa" elementRef="dffa1" x="550.9833333333333" y="1507.9666666666667" relX="0.0" relY="-1.0" />
  </Interaction>
  <Interaction elementID="cfd26" zOrder="12288" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Type your comment here</Comment>
    <Comment>17941718 
Here we show that pharmacological manipulation of the PI3K signaling pathway caused by hypoinsulinemic conditions or selective pharmacological inhibition/activation of PI3K dramatically regulates the ability of AMPH to evokeDAT-mediated DA release in the striatum, as determined byHSCA. 

18614672 
C , D , Representative traces illustrating AMPH evoked DA release in hDAT cells (black) is blocked by 10 M MPH ( C )o r1 0 M cocaine ( D ), whereas 10 M AMPH blocks basal DA efflux in hDAT A559V cells (red) with no further reductions evident with addition of MPH or cocaine. </Comment>
    <CitationRef citationID="e9b" />
    <CitationRef citationID="ef9" />
    <Point elementID="c9520" elementRef="c5ac0" x="483.4916666666667" y="1421.9666666666667" relX="0.5" relY="-1.0" />
    <Point elementID="fb950" elementRef="a1d4c" arrowHead="Arrow" x="677.9833333333333" y="707.0" relX="0.0" relY="1.0" />
  </Interaction>
  <Interaction elementID="cfe9a" zOrder="12288" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Mol Transport HEPES ---| SLC5A7
</Comment>
    <Comment>Thus, the possibility exists that HEPES could cause pH-dependent inhibition of hCHT current (Ming et al., 2002). </Comment>
    <CitationRef citationID="a69" />
    <Point elementID="ce18e" elementRef="d30fb" x="1414.9833333333333" y="451.9666666666667" relX="0.0" relY="-1.0" />
    <Point elementID="c8e84" elementRef="aa11d" arrowHead="TBar" x="1476.975" y="272.0" relX="-0.5" relY="1.0" />
  </Interaction>
  <Interaction elementID="d199d" zOrder="12288" lineThickness="1.0" color="0000ff">
    <Xref dataSource="" identifier="" />
    <Comment>Expression SLC6A2 --+&gt; TH</Comment>
    <Comment>16452680 (Tissue: cortex, CellType: neural, CellLineName: NE) If NET and TH localization are linked to activity states, then chronic stress should increase plasmalemmal NET and TH expression, thus altering the dynamics of NE transmission and impacting cognition and affect. 

</Comment>
    <CitationRef citationID="a35" />
    <Point elementID="f7e12" elementRef="f0d58" x="511.98333333333335" y="266.0" relX="0.0" relY="1.0" />
    <Point elementID="a068e" elementRef="d13b5" arrowHead="mim-necessary-stimulation" x="457.98333333333335" y="694.9666666666667" relX="0.0" relY="-1.0" />
  </Interaction>
  <Interaction elementID="d2ca3" zOrder="12288" lineThickness="1.0" color="990099">
    <Xref dataSource="" identifier="" />
    <Comment>Binding SLC6A4 ---- TGFB1I1</Comment>
    <Comment>16803896 
Associations of SERT with Hic-5 are evident in brain synaptosomes, suggesting the existence of parallel mechanisms operating to regulate SERT at serotonergic synapses.</Comment>
    <CitationRef citationID="a8f" />
    <Point elementID="b6f46" elementRef="b593d" x="892.9916666666667" y="340.9666666666667" relX="0.5" relY="-1.0" />
    <Point elementID="f9a94" elementRef="a1030" x="956.9666666666667" y="294.975" relX="-1.0" relY="-0.5" />
  </Interaction>
  <Interaction elementID="d3282" zOrder="12288" lineThickness="1.0" color="990099">
    <Xref dataSource="" identifier="" />
    <Comment>Binding NOS1 ---- SLC6A4
</Comment>
    <Comment>Evidence of a functional nNOS/SERT association is evident in brain, and synaptosomal 5-HT transport assays using nNOS / mice display increased SERT activity and plasma membrane expression. </Comment>
    <CitationRef citationID="bde" />
    <Point elementID="c7a0c" elementRef="d4621" x="1271.9833333333333" y="664.9666666666667" relX="0.0" relY="-1.0" />
    <Point elementID="eb47d" elementRef="a1030" x="1030.0" y="310.9916666666667" relX="1.0" relY="0.5" />
  </Interaction>
  <Interaction elementID="d33b8" zOrder="12288" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>MolTransport RBL2 ---&gt; serotonin
</Comment>
    <Comment>Results Activation of ARs in RBL-2 H3 Cells Induces an Increase in 5-HT Uptake that Is Enhanced by Sildenafil. </Comment>
    <CitationRef citationID="cb5" />
    <Point elementID="c0799" elementRef="c3ea8" x="1466.4833333333333" y="1411.9666666666667" relX="0.0" relY="-1.0" />
    <Point elementID="c8a27" elementRef="d95ce" arrowHead="Arrow" x="1317.9833333333333" y="589.0" relX="0.0" relY="1.0" />
  </Interaction>
  <Interaction elementID="d5d84" zOrder="12288" lineThickness="1.0" color="009999">
    <Xref dataSource="" identifier="" />
    <Comment>MolSynthesis SLC6A4 ---&gt; serotonin
</Comment>
    <Comment>The active transport of 5-HT byplatelet SERT is thought to be important in maintaining thecirculating concentration of 5-HT below the levels required toactivate vascular smooth cells and platelet 5-HT receptors(Stoltz, 1985; Nemeroff et al., 1998; Musselman et al., 2002).Therefore, the above-mentioned findings suggest that SERTfunction in platelets may be regulated by kinases and phos-phatases linked to endogenous receptors and that this regu-lation may play a role in maintaining blood 5-HT levels.</Comment>
    <CitationRef citationID="dab" />
    <Point elementID="a6efd" elementRef="a1030" x="1030.0" y="302.98333333333335" relX="1.0" relY="0.0" />
    <Point elementID="abd1b" elementRef="d95ce" arrowHead="Arrow" x="1282.9666666666667" y="563.475" relX="-1.0" relY="-0.5" />
  </Interaction>
  <Interaction elementID="d9eaa" zOrder="12288" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Mol Transport SLC6A2 ---&gt; dopamine</Comment>
    <Comment>16452680 
However, one would expect NE axons to express more plasmalemmal NET to facilitate DA uptake. 

15103690
Given the ability of NET to transport DA (Horn, 1973; Raiteri et al., 1977; Gu et al., 1996), one probable mechanism by which NET inhibitors might increase DA levels is by blocking an important clearance mechanism for DA 

14566944 
One potentialmechanism may rely on the ability of NET to transport DA(Horn, 1973; Raiteri et al., 1977; Gu et al., 1996). </Comment>
    <CitationRef citationID="a35" />
    <CitationRef citationID="f52" />
    <CitationRef citationID="b83" />
    <Point elementID="cc356" elementRef="f0d58" x="548.0" y="258.2416666666667" relX="1.0" relY="0.5" />
    <Point elementID="d4a80" elementRef="a1d4c" arrowHead="Arrow" x="660.975" y="674.9666666666667" relX="-0.5" relY="-1.0" />
  </Interaction>
  <Interaction elementID="db3b7" zOrder="12288" lineStyle="Broken" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Regulation citalopram ---| SLC6A4</Comment>
    <Comment>16803896 
The activation and MS localizationof SERT are inhibited by citalopram, leading to an accumulation of SERTs inthe cytoskeletal-associated fractions and concomitant increase in associa-tions with Hic-5 (CS).</Comment>
    <CitationRef citationID="a8f" />
    <Point elementID="d6cc4" elementRef="d8f25" x="923.4833333333333" y="492.9666666666667" relX="0.0" relY="-1.0" />
    <Point elementID="b5c0b" elementRef="a1030" arrowHead="TBar" x="975.225" y="319.0" relX="-0.5" relY="1.0" />
  </Interaction>
  <Interaction elementID="dc02e" zOrder="12288" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Mol Transport SYN1 ---&gt; epinephrine
</Comment>
    <Comment>SYN1A influenced NE transport only in the prese nce of Ca 2+ in brain cortical synaptosomes. </Comment>
    <CitationRef citationID="f47" />
    <Point elementID="fa445" elementRef="dffa1" x="550.9833333333333" y="1507.9666666666667" relX="0.0" relY="-1.0" />
    <Point elementID="d2dfd" elementRef="c7403" arrowHead="Arrow" x="590.4833333333333" y="1213.0" relX="0.0" relY="1.0" />
  </Interaction>
  <Interaction elementID="dc118" zOrder="12288" lineStyle="Broken" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Regulation TGFB1I1 ---| SLC6A4</Comment>
    <Comment>16803896 
Hic-5 may compete with otherproteins like MacMARKS that stabilize SERT localization tothe MS leading to SERT inactivation and eventually transporterendocytosis.</Comment>
    <CitationRef citationID="a8f" />
    <Point elementID="a49d0" elementRef="b593d" x="906.0" y="348.975" relX="1.0" relY="-0.5" />
    <Point elementID="a9d48" elementRef="a1030" arrowHead="TBar" x="956.9666666666667" y="302.98333333333335" relX="-1.0" relY="0.0" />
  </Interaction>
  <Interaction elementID="dc907" zOrder="12288" lineThickness="1.0" color="0000ff">
    <Xref dataSource="" identifier="" />
    <Comment>Expression ACHE --+&gt; SLC5A7
</Comment>
    <Comment>However, AChE / mice did show a dramatic increase in CHT expression.</Comment>
    <CitationRef citationID="a0f" />
    <Point elementID="ac51b" elementRef="f3fbf" x="1636.9833333333333" y="880.9666666666667" relX="0.0" relY="-1.0" />
    <Point elementID="b165c" elementRef="aa11d" arrowHead="mim-necessary-stimulation" x="1512.9916666666668" y="272.0" relX="0.5" relY="1.0" />
  </Interaction>
  <Interaction elementID="dd157" zOrder="12288" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Mol Transport PVRL2 ---&gt; dopamine</Comment>
    <Comment>18614672 
C , D , Representative traces illustrating AMPH evoked DA release in hDAT cells (black) is blocked by 10 M MPH ( C )o r1 0 M cocaine ( D ), whereas 10 M AMPH blocks basal DA efflux in hDAT A559V cells (red) with no further reductions evident with addition of MPH or cocaine.</Comment>
    <CitationRef citationID="ef9" />
    <Point elementID="b8dce" elementRef="d304b" x="653.9833333333333" y="184.99999999999994" relX="0.0" relY="1.0" />
    <Point elementID="ad9a4" elementRef="a1d4c" arrowHead="Arrow" x="677.9833333333333" y="674.9666666666667" relX="0.0" relY="-1.0" />
  </Interaction>
  <Interaction elementID="df006" zOrder="12288" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>MolTransport IL1B ---&gt; serotonin
</Comment>
    <Comment>16452991 
Stimulation of 5-HT Uptake in Mouse Synaptosomes by IL-1 b and TNFa To assess the relevanc e o f o u r findings with cultured raphe cells for native bra in system s, synapto somes were prepared from midbra in and striatu m o f C57B L/6 mice and treat ed with IL-1 b or TNFa 

</Comment>
    <CitationRef citationID="d77" />
    <Point elementID="eea41" elementRef="dfe0c" x="1211.4833333333333" y="98.0" relX="0.0" relY="1.0" />
    <Point elementID="f61d7" elementRef="d95ce" arrowHead="Arrow" x="1300.475" y="554.9666666666667" relX="-0.5" relY="-1.0" />
  </Interaction>
  <Interaction elementID="df773" zOrder="12288" lineStyle="Broken" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Regulation MAPK14 --+&gt; SLC6A4
</Comment>
    <Comment>16452991 
We have demonstrated that activation of p38 mitogen-activated protein kinase (MAPK) induces a catalytic activation of the serotonin transporter (SERT) arising from a reduction in the SERT K m for 5-hydroxytryptamine (5-HT). </Comment>
    <CitationRef citationID="d77" />
    <Point elementID="afebe" elementRef="a34e2" x="1036.9666666666667" y="711.225" relX="-1.0" relY="-0.5" />
    <Point elementID="e0090" elementRef="a1030" arrowHead="mim-necessary-stimulation" x="993.4833333333333" y="319.0" relX="0.0" relY="1.0" />
  </Interaction>
  <Interaction elementID="e1b82" zOrder="12288" lineThickness="1.0" color="990099">
    <Xref dataSource="" identifier="" />
    <Comment>Binding SLC6A1 ---- STX1A</Comment>
    <Comment>12629174 
Moreover, evidence has been gathered thatsyntaxin 1A forms physical complexes with the NET homologuesGAT1 and GLYT1 (Beckman et al., 1998; Geerlings et al., 2000).In particular, the GAT1 GABA transporters interact with syn-taxin 1A in a phorbol ester-sensitive manner, with evidence thatmultiple PKC-linked receptors can trigger GAT1 redistributionand syntaxin 1A/GAT1 complex disassembly.</Comment>
    <CitationRef citationID="fa0" />
    <Point elementID="d1e89" elementRef="dcd2c" x="678.9833333333333" y="1420.9666666666667" relX="0.0" relY="-1.0" />
    <Point elementID="cd636" elementRef="f9dec" x="865.9833333333333" y="299.0" relX="0.0" relY="1.0" />
  </Interaction>
  <Interaction elementID="e1bc6" zOrder="12288" lineThickness="1.0" color="009999">
    <Xref dataSource="" identifier="" />
    <Comment>MolSynthesis TPH2 ---&gt; serotonin
</Comment>
    <Comment>Zhang X, Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG (2004) Tryptophan hydroxylase-2 controls brain serotonin synthesis. </Comment>
    <CitationRef citationID="b65" />
    <Point elementID="c13f8" elementRef="a26a3" x="1434.4833333333333" y="740.9666666666667" relX="0.0" relY="-1.0" />
    <Point elementID="ea551" elementRef="d95ce" arrowHead="Arrow" x="1335.4916666666668" y="589.0" relX="0.5" relY="1.0" />
  </Interaction>
  <Interaction elementID="e213c" zOrder="12288" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Mol Transport SLC6A4 ---&gt; serotonin
</Comment>
    <Comment>15774771 
Early studies using heterologously expressed hSERTin HEK-293 cells showed that -PMA increased SERT phosphorylation with parallel decreases in the V max for uptake of 5-HT and surface SERT density (Qian et al., 1997; Ramamoorthy et al., 1998a). 

18445122 
In the absence of nNOS, SERT may remain at the cell surface or target the plasma membrane through a constitutive pathway and thus exhibit theobserved elevations in basal 5-HT transport activity.</Comment>
    <CitationRef citationID="dab" />
    <CitationRef citationID="bde" />
    <Point elementID="ce281" elementRef="a1030" x="1030.0" y="310.9916666666667" relX="1.0" relY="0.5" />
    <Point elementID="a2a81" elementRef="d95ce" arrowHead="Arrow" x="1282.9666666666667" y="580.4916666666667" relX="-1.0" relY="0.5" />
  </Interaction>
  <Interaction elementID="e4914" zOrder="12288" lineStyle="Broken" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Regulation STX1A ---| SLC6A1</Comment>
    <Comment>12629174 
Because BoNT/C1 signifi-cantly diminishes GAT1 surface levels, a greater fraction of totalGAT1 proteins may be inhibited constitutively at the plasmamembrane by syntaxin 1A, whereas NET resides mainly intracel-lular, awaiting SNARE-dependent trafficking to the plasmamembrane. </Comment>
    <CitationRef citationID="fa0" />
    <Point elementID="b92d0" elementRef="dcd2c" x="678.9833333333333" y="1420.9666666666667" relX="0.0" relY="-1.0" />
    <Point elementID="eb539" elementRef="f9dec" arrowHead="TBar" x="847.975" y="299.0" relX="-0.5" relY="1.0" />
  </Interaction>
  <Interaction elementID="e4fa9" zOrder="12288" lineThickness="1.0" color="0000ff">
    <Xref dataSource="" identifier="" />
    <Comment>Expression MAPK14 --+&gt; SLC6A4
</Comment>
    <Comment>15774771 
Theseresults suggest that whereas PKC is involved in regulatedexpression of SERT, p38 MAPK may be involved in main-taining normal/basal expression of SERT</Comment>
    <CitationRef citationID="dab" />
    <Point elementID="d564b" elementRef="a34e2" x="1089.4916666666668" y="701.9666666666667" relX="0.5" relY="-1.0" />
    <Point elementID="bc18f" elementRef="a1030" arrowHead="mim-necessary-stimulation" x="1011.7416666666667" y="319.0" relX="0.5" relY="1.0" />
  </Interaction>
  <Interaction elementID="e51de" zOrder="12288" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Mol Transport AMPH ---&gt; noradrenaline
</Comment>
    <Comment>AMPH induces NE efflux and may also regulate transporter trafficking.</Comment>
    <CitationRef citationID="b9f" />
    <Point elementID="fddca" elementRef="c5ac0" x="448.475" y="1421.9666666666667" relX="-0.5" relY="-1.0" />
    <Point elementID="c0faa" elementRef="ed41e" arrowHead="Arrow" x="569.475" y="817.0" relX="-0.5" relY="1.0" />
  </Interaction>
  <Interaction elementID="e6675" zOrder="12288" lineThickness="1.0" color="999900">
    <Xref dataSource="" identifier="" />
    <Comment>ProtModification MAPK14 ---&gt; CDC25C
</Comment>
    <Comment>Phosphorylation of Cdc25 and tuberin by p38 MAPK enhances interac-tion of these proteins with 14-3-3 [58,59] .</Comment>
    <CitationRef citationID="ccb" />
    <Point elementID="cf3e0" elementRef="a34e2" x="1054.475" y="739.0" relX="-0.5" relY="1.0" />
    <Point elementID="a2ef4" elementRef="fbe48" arrowHead="Arrow" x="1041.9833333333333" y="893.9666666666667" relX="0.0" relY="-1.0" />
  </Interaction>
  <Interaction elementID="e7f2c" zOrder="12288" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Mol Transport TNF ---&gt; serotonin
</Comment>
    <Comment>RESULTS Stimulation of 5-HT Uptake in RN46A Cells by IL-1 b and TNFa IL-1 b ex erted a concen trationand tim e-dependen t sti mulation of 5-HT trans port activ ity in cultured RN46A cells (Figure 1a and b).</Comment>
    <CitationRef citationID="d77" />
    <Point elementID="b1684" elementRef="f45dd" x="1348.4833333333333" y="87.0" relX="0.0" relY="1.0" />
    <Point elementID="d4f06" elementRef="d95ce" arrowHead="Arrow" x="1335.4916666666668" y="554.9666666666667" relX="0.5" relY="-1.0" />
  </Interaction>
  <Interaction elementID="e993a" zOrder="12288" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Point elementID="a97bc" elementRef="a34e2" x="1107.0" y="711.225" relX="1.0" relY="-0.5" />
    <Point elementID="f19de" elementRef="a1030" arrowHead="Arrow" x="1011.7416666666667" y="319.0" relX="0.5" relY="1.0" />
  </Interaction>
  <Interaction elementID="ea468" zOrder="12288" lineStyle="Broken" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Regulation AMPH ---&gt; SYN1</Comment>
    <Comment>Here, we demonstrate that AMPH stimulation of CAMKII stabilizes an hNET/SYN1A complex. </Comment>
    <CitationRef citationID="b9f" />
    <Point elementID="bc6ab" elementRef="c5ac0" x="465.98333333333335" y="1460.0" relX="0.0" relY="1.0" />
    <Point elementID="c6d85" elementRef="dffa1" arrowHead="Arrow" x="533.475" y="1507.9666666666667" relX="-0.5" relY="-1.0" />
  </Interaction>
  <Interaction elementID="eaaeb" zOrder="12288" lineThickness="1.0" color="0000ff">
    <Xref dataSource="" identifier="" />
    <Comment>Expression MAPK14 --+&gt; TNFRSF11B
</Comment>
    <Comment>Inflammatory cytokines activate p38 MAPK to induce osteoprotegerin synthesis by MG-63 cells.</Comment>
    <CitationRef citationID="d77" />
    <Point elementID="b3cfc" elementRef="a34e2" x="1107.0" y="711.225" relX="1.0" relY="-0.5" />
    <Point elementID="bd154" elementRef="e4546" arrowHead="Arrow" x="1210.4833333333333" y="247.99999999999994" relX="0.0" relY="1.0" />
  </Interaction>
  <Interaction elementID="ecaed" zOrder="12288" lineThickness="1.0" color="660066">
    <Xref dataSource="" identifier="" />
    <Comment>Binding SLC6A4 ---- TDO2
</Comment>
    <Comment>19179283 
Traitsinfluenced by interactions of Slc6a4 and Tph2 variants are prov ided in Table S2 (independent Tph2 -associated traits are pre sented in Table S3 ). CONTEXT{11012153} </Comment>
    <CitationRef citationID="b65" />
    <Point elementID="cf087" elementRef="e7ff2" x="975.9833333333333" y="700.9666666666667" relX="0.0" relY="-1.0" />
    <Point elementID="b3036" elementRef="a1030" x="975.225" y="319.0" relX="-0.5" relY="1.0" />
  </Interaction>
  <Interaction elementID="ed028" zOrder="12288" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>MolTransport STX1A ---&gt; noradrenaline</Comment>
    <Comment>Results NET-mediated NE transport requires syntaxin 1A To evaluate the syntaxin 1A dependence of NET-mediated NEtransport, we established hNET stably transfected CAD cells(CADhNET) and examined whether antisense oligonucleotide-mediated suppression of syntaxin 1A synthesis would influenceNE transport.</Comment>
    <CitationRef citationID="fa0" />
    <Point elementID="bd4af" elementRef="dcd2c" x="661.475" y="1420.9666666666667" relX="-0.5" relY="-1.0" />
    <Point elementID="bbaa3" elementRef="ed41e" arrowHead="Arrow" x="586.9833333333333" y="817.0" relX="0.0" relY="1.0" />
  </Interaction>
  <Interaction elementID="ed1ea" zOrder="12288" lineThickness="1.0" color="0000ff">
    <Xref dataSource="" identifier="" />
    <Comment>Expression TNF --+&gt; FBXO32
</Comment>
    <Comment>TNFalpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle.</Comment>
    <CitationRef citationID="d77" />
    <Point elementID="ea612" elementRef="f45dd" x="1365.7416666666668" y="87.0" relX="0.5" relY="1.0" />
    <Point elementID="f9ca1" elementRef="fa226" arrowHead="mim-necessary-stimulation" x="1653.9833333333333" y="339.9666666666667" relX="0.0" relY="-1.0" />
  </Interaction>
  <Interaction elementID="efbbf" zOrder="12288" lineThickness="1.0" color="009999">
    <Xref dataSource="" identifier="" />
    <Comment>Mol Synthesis AGT ---&gt; noradrenaline</Comment>
    <Comment>14697674
Norepinephrine metabolism in neuronal cultures is increased by angiotensin II.Am.</Comment>
    <CitationRef citationID="a0b" />
    <Point elementID="e6acf" elementRef="f01fc" x="567.4833333333333" y="92.0" relX="0.0" relY="1.0" />
    <Point elementID="a13cb" elementRef="ed41e" arrowHead="Arrow" x="604.4916666666667" y="779.9666666666667" relX="0.5" relY="-1.0" />
  </Interaction>
  <Interaction elementID="f2823" zOrder="12288" lineStyle="Broken" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Regulation reserpine --+&gt; TH
</Comment>
    <Comment>Reserpine selectively increases tyrosine hydroxylase and dopaminebeta-hydroxylase enzyme protein in central noradrenergic neurons. </Comment>
    <CitationRef citationID="b83" />
    <Point elementID="e43fb" elementRef="efbe4" x="402.2091397849463" y="891.9666666666667" relX="0.0" relY="-1.0" />
    <Point elementID="d768a" elementRef="d13b5" arrowHead="mim-necessary-stimulation" x="457.98333333333335" y="733.0" relX="0.0" relY="1.0" />
  </Interaction>
  <Interaction elementID="f6739" zOrder="12288" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>Mol Transport SLC5A7 ---&gt; Hemicholinium-3
</Comment>
    <Comment>Constitutive leak currents through hCHT depolarize oocytes The selective blocker HC-3 reveals a leak current through hCHT in the absence of choline.</Comment>
    <CitationRef citationID="a69" />
    <Point elementID="cb950" elementRef="aa11d" x="1494.9833333333333" y="272.0" relX="0.0" relY="1.0" />
    <Point elementID="ab4e6" elementRef="efefa" arrowHead="Arrow" x="1546.9833333333333" y="813.9666666666667" relX="0.0" relY="-1.0" />
  </Interaction>
  <Interaction elementID="f8459" zOrder="12288" lineThickness="1.0" color="990099">
    <Xref dataSource="" identifier="" />
    <Comment>Binding SCAMP2 ---- SLC6A4
</Comment>
    <Comment>18445122 
After confirmation of a native SCAMP2/SERT complex in glutathione S-transferase pull-down assays, these inves-tigators documented a decreased V max of 5-HT transport wh en S CA MP 2 an d S E RT we re c oe x p re s se d in t ra n sf e c te d ce ll s . </Comment>
    <CitationRef citationID="bde" />
    <Point elementID="dec5c" elementRef="b270c" x="781.9833333333333" y="1494.9666666666667" relX="0.0" relY="-1.0" />
    <Point elementID="c35a9" elementRef="a1030" x="975.225" y="319.0" relX="-0.5" relY="1.0" />
  </Interaction>
  <Interaction elementID="fad5d" zOrder="12288" lineStyle="Broken" lineThickness="1.0">
    <Xref dataSource="" identifier="" />
    <Comment>MolTransport MAPK14 --+&gt; SLC6A4
</Comment>
    <Comment>18317590
Tonic activation p38 MAPK signal ing pathways, without direct phosphorylation of the transporter, controls basal surface SERT expression levels, whereas acute p38 MAPK activation induces trafficking-independent stimulation of SERT transport activity (12, 16). </Comment>
    <CitationRef citationID="ad9" />
    <Point elementID="bc8cf" elementRef="a34e2" x="1071.9833333333333" y="701.9666666666667" relX="0.0" relY="-1.0" />
    <Point elementID="a9170" elementRef="a1030" arrowHead="mim-necessary-stimulation" x="1011.7416666666667" y="319.0" relX="0.5" relY="1.0" />
  </Interaction>
  <Interaction elementID="fbd63" zOrder="12288" lineThickness="1.0" color="990099">
    <Xref dataSource="" identifier="" />
    <Comment>Binding PPP2CB ---- SLC6A4
</Comment>
    <Comment>18445122 
The simplest scenario (Figure 3) consistent with the existing data thus involves SERT/PP2Ac associa-tions that are enriched in plasma membrane domains containing active SERT, whereas less active SERT pools and inactivated (and possibly recycling) SERTs beingrelatively deficient in SERT/PP2Ac complexes.

15728187 
We speculate that p38 MAPKmay either augment or stabilize SERT/PP2Ac associations, or,alternatively, p38 MAPK may enhance PP2A activity withinmembrane-resident, transporter-phosphatase complexes.</Comment>
    <CitationRef citationID="bde" />
    <CitationRef citationID="ead" />
    <Point elementID="bd470" elementRef="ab696" x="949.9833333333333" y="603.9666666666667" relX="0.0" relY="-1.0" />
    <Point elementID="ac2bc" elementRef="a1030" x="975.225" y="319.0" relX="-0.5" relY="1.0" />
  </Interaction>
  <GraphicalLine elementID="a7e8f" zOrder="12288" lineThickness="1.0" color="cccc00">
    <Point elementID="ecde0" x="35.714285714285694" y="1169.6428571428567" />
    <Point elementID="cf76f" arrowHead="Arrow" x="112.24489795918362" y="1169.6428571428567" />
  </GraphicalLine>
  <GraphicalLine elementID="a9013" zOrder="12288" lineThickness="1.0" color="0000ff">
    <Point elementID="d1f00" x="31.887755102040806" y="1020.4081632653065" />
    <Point elementID="d23c4" arrowHead="mim-necessary-stimulation" x="114.79591836734696" y="1020.4081632653065" />
  </GraphicalLine>
  <GraphicalLine elementID="bc88e" zOrder="12288" lineThickness="1.0" color="009999">
    <Point elementID="b15ee" x="31.887755102040785" y="1051.020408163265" />
    <Point elementID="c9ed6" arrowHead="Arrow" x="114.79591836734701" y="1051.020408163265" />
  </GraphicalLine>
  <GraphicalLine elementID="c6322" zOrder="12288" lineThickness="1.0">
    <Point elementID="bdd29" x="35.71428571428571" y="1089.285714285715" />
    <Point elementID="b78d5" arrowHead="Arrow" x="113.52040816326534" y="1089.285714285715" />
  </GraphicalLine>
  <GraphicalLine elementID="dc140" zOrder="12288" lineThickness="1.0" color="cc00cc">
    <Point elementID="b2e2a" x="33.16326530612244" y="991.0714285714286" />
    <Point elementID="fab6d" x="107.14285714285718" y="991.0714285714286" />
  </GraphicalLine>
  <GraphicalLine elementID="f98f8" zOrder="12288" lineThickness="1.0">
    <Point elementID="a7f94" x="36.989795918367285" y="1210.45918367347" />
    <Point elementID="a21fb" arrowHead="TBar" x="108.41836734693891" y="1211.7346938775515" />
  </GraphicalLine>
  <GraphicalLine elementID="feabc" zOrder="12288" lineStyle="Broken" lineThickness="1.0">
    <Point elementID="c2204" x="39.5408163265306" y="1132.6530612244908" />
    <Point elementID="ac4c1" arrowHead="mim-necessary-stimulation" x="107.14285714285715" y="1132.6530612244908" />
  </GraphicalLine>
  <GraphicalLine elementID="f9b16" zOrder="32849" lineThickness="1.0" color="0000ff">
    <Point elementID="fac84" x="36.785714285714214" y="1248.520408163267" />
    <Point elementID="f3c3e" arrowHead="TBar" x="108.2142857142859" y="1249.7959183673483" />
  </GraphicalLine>
  <GraphicalLine elementID="d3b4a" zOrder="32850" lineStyle="Broken" lineThickness="1.0">
    <Point elementID="abea2" x="38.06122448979585" y="1281.6836734693889" />
    <Point elementID="dd142" arrowHead="TBar" x="109.48979591836752" y="1282.9591836734703" />
  </GraphicalLine>
  <Label elementID="a15d9" textLabel="LEGEND" fillColor="ffffff" fontWeight="Bold" fontSize="13" vAlign="Middle" centerX="79.0" centerY="946.0" width="80.0" height="20.0" zOrder="28672" />
  <Label elementID="ac174" textLabel="Transport" fillColor="ffffff" fontSize="10" vAlign="Middle" centerX="156.0" centerY="1088.0" width="80.0" height="20.0" zOrder="28672" />
  <Label elementID="b6f6f" textLabel="Cell Membrane" fillColor="ffffff" fontWeight="Bold" fontSize="13" vAlign="Middle" groupRef="a03d3" centerX="909.0" centerY="190.0" width="106.0" height="24.0" zOrder="28672" />
  <Label elementID="bd146" textLabel="Expression" fillColor="ffffff" fontSize="10" vAlign="Middle" centerX="159.0" centerY="1020.5510204081634" width="80.0" height="20.0" zOrder="28672" />
  <Label elementID="d07fc" textLabel="Negative Regulation" fillColor="ffffff" fontSize="10" vAlign="Middle" centerX="184.5" centerY="1279.0" width="107.0" height="20.0" zOrder="28672" />
  <Label elementID="d46e7" textLabel="Protein Modification" fillColor="ffffff" fontSize="10" vAlign="Middle" centerX="183.0" centerY="1170.0" width="108.0" height="20.0" zOrder="28672" />
  <Label elementID="debf9" textLabel="Binding" fillColor="ffffff" fontSize="10" vAlign="Middle" centerX="151.0" centerY="989.0" width="80.0" height="20.0" zOrder="28672" />
  <Label elementID="e2bb1" textLabel="Negative Transport" fillColor="ffffff" fontSize="10" vAlign="Middle" centerX="180.0" centerY="1209.0" width="102.0" height="20.0" zOrder="28672" />
  <Label elementID="e578b" textLabel="Golgi" fillColor="ffffff" fontWeight="Bold" fontSize="13" vAlign="Middle" groupRef="ace3b" centerX="669.0" centerY="1516.0" width="80.0" height="20.0" zOrder="28672" />
  <Label elementID="e7bd1" textLabel="Protein" fillColor="ffffff" fontSize="10" vAlign="Middle" centerX="153.0" centerY="1356.0" width="80.0" height="20.0" zOrder="28672" />
  <Label elementID="f0019" textLabel="Negative Expression" fillColor="ffffff" fontSize="10" vAlign="Middle" centerX="183.0" centerY="1248.0" width="106.0" height="20.0" zOrder="28672" />
  <Label elementID="f3d6e" textLabel="Nucleus" fillColor="ffffff" fontWeight="Bold" fontSize="13" vAlign="Middle" groupRef="be2c1" centerX="1394.0" centerY="1548.0" width="80.0" height="20.0" zOrder="28672" />
  <Label elementID="f661d" textLabel="Synthesis " fillColor="ffffff" fontSize="10" vAlign="Middle" centerX="157.0" centerY="1050.0" width="80.0" height="20.0" zOrder="28672" />
  <Label elementID="f792e" textLabel="Regulation" fillColor="ffffff" fontSize="10" vAlign="Middle" centerX="161.0" centerY="1131.0" width="80.0" height="20.0" zOrder="28672" />
  <Label elementID="fba45" textLabel="Small Molecule" fillColor="ffffff" fontSize="10" vAlign="Middle" centerX="174.5" centerY="1407.0" width="89.0" height="20.0" zOrder="28672" />
  <Shape elementID="e68b6" groupRef="ace3b" shapeType="Oval" lineStyle="Broken" color="fbe3ca" fillColor="f6e0ca" fontSize="10" vAlign="Middle" centerX="634.325361081438" centerY="1439.4756224618652" width="437.9388548653521" height="46.85132734841424" zOrder="-14" rotation="0.01120945499987308" />
  <Shape elementID="d4fad" groupRef="ace3b" shapeType="Oval" lineStyle="Broken" color="fbe3ca" fillColor="f6e0ca" fontSize="10" vAlign="Middle" centerX="630.4833333333333" centerY="1481.0" width="373.03333333333336" height="40.0" zOrder="-13" rotation="0.0" />
  <Shape elementID="aaccd" groupRef="ace3b" shapeType="Oval" lineStyle="Broken" color="fbe3ca" fillColor="f6e0ca" fontSize="10" vAlign="Middle" centerX="634.9833333333333" centerY="1525.0" width="456.03333333333336" height="48.0" zOrder="-12" rotation="0.0" />
  <Shape elementID="b244b" groupRef="a03d3" shapeType="Rectangle" lineStyle="Broken" color="ffffcc" fillColor="ffffcc" fontSize="10" vAlign="Middle" centerX="1009.9833333333333" centerY="237.98333333333332" width="1378.0333333333333" height="178.03333333333333" zOrder="-10" rotation="0.0">
    <Comment>Cell Membrane</Comment>
  </Shape>
  <Shape elementID="da8db" groupRef="a03d3" shapeType="Rectangle" lineStyle="Broken" color="ffff99" fillColor="ffff99" fontSize="10" vAlign="Middle" centerX="1007.9833333333333" centerY="161.98333333333332" width="1372.0333333333333" height="24.033333333333335" zOrder="-9" rotation="0.0">
    <Comment>Outer Membrane</Comment>
  </Shape>
  <Shape elementID="b0105" groupRef="a03d3" shapeType="Rectangle" lineStyle="Broken" color="ffff99" fillColor="ffff99" fontSize="10" vAlign="Middle" centerX="1010.4833333333333" centerY="314.48333333333335" width="1379.0333333333333" height="25.033333333333335" zOrder="-7" rotation="0.0">
    <Comment>Inner Membrane</Comment>
  </Shape>
  <Shape elementID="d9ab8" shapeType="Rectangle" color="cc0000" fontSize="10" vAlign="Middle" centerX="68.48333333333333" centerY="1356.9833333333333" width="69.03333333333333" height="26.033333333333335" zOrder="16384" rotation="0.0" />
  <Shape elementID="ec0c4" shapeType="Rectangle" color="00cc00" fontSize="10" vAlign="Middle" centerX="69.48333333333333" centerY="1407.9833333333333" width="69.03333333333333" height="26.033333333333335" zOrder="16384" rotation="0.0" />
  <Shape elementID="a8b80" groupRef="be2c1" shapeType="Oval" lineStyle="Broken" color="e9eff6" fillColor="e3f0fc" fontSize="10" vAlign="Middle" centerX="1395.3533237048355" centerY="1527.1248954621924" width="284.53483804716836" height="274.55849011511395" zOrder="16388" rotation="0.040120660313065305">
    <Comment>Nucleus</Comment>
  </Shape>
  <Group elementID="a03d3" groupType="Group" />
  <Group elementID="ace3b" groupType="Group" />
  <Group elementID="be2c1" groupType="Group" />
  <InfoBox centerX="0.0" centerY="0.0" />
  <Citations>
    <Citation citationID="a55" URL="" title="A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters." year="2003" source="J Neurosci">
      <Xref dataSource="PubMed" identifier="12805287" />
      <Author name="Hahn MK" />
      <Author name="Robertson D" />
      <Author name="Blakely RD" />
    </Citation>
    <Citation citationID="d51" URL="" title="Cholinergic neurons of mouse intrinsic cardiac ganglia contain noradrenergic enzymes, norepinephrine transporters, and the neurotrophin receptors tropomyosin-related kinase A and p75." year="2008" source="Neuroscience">
      <Xref dataSource="PubMed" identifier="18674600" />
      <Author name="Hoard JL" />
      <Author name="Hoover DB" />
      <Author name="Mabe AM" />
      <Author name="Blakely RD" />
      <Author name="Feng N" />
      <Author name="Paolocci N" />
    </Citation>
    <Citation citationID="f52" URL="" title="Ultrastructural interactions between terminals expressing the norepinephrine transporter and dopamine neurons in the rat and monkey ventral tegmental area." year="2004" source="Synapse">
      <Xref dataSource="PubMed" identifier="15103690" />
      <Author name="Liprando LA" />
      <Author name="Miner LH" />
      <Author name="Blakely RD" />
      <Author name="Lewis DA" />
      <Author name="Sesack SR" />
    </Citation>
    <Citation citationID="a35" URL="" title="Chronic stress increases the plasmalemmal distribution of the norepinephrine transporter and the coexpression of tyrosine hydroxylase in norepinephrine axons in the prefrontal cortex." year="2006" source="J Neurosci">
      <Xref dataSource="PubMed" identifier="16452680" />
      <Author name="Miner LH" />
      <Author name="Jedema HP" />
      <Author name="Moore FW" />
      <Author name="Blakely RD" />
      <Author name="Grace AA" />
      <Author name="Sesack SR" />
    </Citation>
    <Citation citationID="ccb" URL="" title="Proteomic analysis of human norepinephrine transporter complexes reveals associations with protein phosphatase 2A anchoring subunit and 14-3-3 proteins." year="2005" source="Biochem Biophys Res Commun">
      <Xref dataSource="PubMed" identifier="15963952" />
      <Author name="Sung U" />
      <Author name="Jennings JL" />
      <Author name="Link AJ" />
      <Author name="Blakely RD" />
    </Citation>
    <Citation citationID="dab" URL="" title="Evidence for biphasic effects of protein kinase C on serotonin transporter function, endocytosis, and phosphorylation." year="2005" source="Mol Pharmacol">
      <Xref dataSource="PubMed" identifier="15774771" />
      <Author name="Jayanthi LD" />
      <Author name="Samuvel DJ" />
      <Author name="Blakely RD" />
      <Author name="Ramamoorthy S" />
    </Citation>
    <Citation citationID="d77" URL="" title="The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters." year="2006" source="Neuropsychopharmacology">
      <Xref dataSource="PubMed" identifier="16452991" />
      <Author name="Zhu CB" />
      <Author name="Blakely RD" />
      <Author name="Hewlett WA" />
    </Citation>
    <Citation citationID="c58" URL="" title="Developing novel treatments for mood disorders: accelerating discovery." year="2002" source="Biol Psychiatry">
      <Xref dataSource="PubMed" identifier="12361670" />
      <Author name="Tamminga CA" />
      <Author name="Nemeroff CB" />
      <Author name="Blakely RD" />
      <Author name="Brady L" />
      <Author name="Carter CS" />
      <Author name="Davis KL" />
      <Author name="Dingledine R" />
      <Author name="Gorman JM" />
      <Author name="Grigoriadis DE" />
      <Author name="Henderson DC" />
      <Author name="B Innis RB" />
      <Author name="Killen J" />
      <Author name="Laughren TP" />
      <Author name="McDonald WM" />
      <Author name="M Murphy GM Jr" />
      <Author name="Paul SM" />
      <Author name="Rudorfer MV" />
      <Author name="Sausville E" />
      <Author name="Schatzberg AF" />
      <Author name="Scolnick EM" />
      <Author name="Suppes T" />
    </Citation>
    <Citation citationID="ead" URL="" title="p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process." year="2005" source="J Biol Chem">
      <Xref dataSource="PubMed" identifier="15728187" />
      <Author name="Zhu CB" />
      <Author name="Carneiro AM" />
      <Author name="Dostmann WR" />
      <Author name="Hewlett WA" />
      <Author name="Blakely RD" />
    </Citation>
    <Citation citationID="a8f" URL="" title="Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter." year="2006" source="J Biol Chem">
      <Xref dataSource="PubMed" identifier="16803896" />
      <Author name="Carneiro AM" />
      <Author name="Blakely RD" />
    </Citation>
    <Citation citationID="a0b" URL="" title="Cell surface trafficking of the antidepressant-sensitive norepinephrine transporter revealed with an ectodomain antibody." year="2003" source="Mol Cell Neurosci">
      <Xref dataSource="PubMed" identifier="14697674" />
      <Author name="Savchenko V" />
      <Author name="Sung U" />
      <Author name="Blakely RD" />
    </Citation>
    <Citation citationID="fa0" URL="" title="A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity." year="2003" source="J Neurosci">
      <Xref dataSource="PubMed" identifier="12629174" />
      <Author name="Sung U" />
      <Author name="Apparsundaram S" />
      <Author name="Galli A" />
      <Author name="Kahlig KM" />
      <Author name="Savchenko V" />
      <Author name="Schroeter S" />
      <Author name="Quick MW" />
      <Author name="Blakely RD" />
    </Citation>
    <Citation citationID="fc1" URL="" title="Anomalous dopamine release associated with a human dopamine transporter coding variant." year="2008" source="J Neurosci">
      <Xref dataSource="PubMed" identifier="18614672" />
      <Author name="Mazei-Robison MS" />
      <Author name="Bowton E" />
      <Author name="Holy M" />
      <Author name="Schmudermaier M" />
      <Author name="Freissmuth M" />
      <Author name="Sitte HH" />
      <Author name="Galli A" />
      <Author name="Blakely RD" />
    </Citation>
    <Citation citationID="a0f" URL="" title="Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice." year="2003" source="Mol Pharmacol">
      <Xref dataSource="PubMed" identifier="14645660" />
      <Author name="Volpicelli-Daley LA" />
      <Author name="Hrabovska A" />
      <Author name="Duysen EG" />
      <Author name="Ferguson SM" />
      <Author name="Blakely RD" />
      <Author name="Lockridge O" />
      <Author name="Levey AI" />
    </Citation>
    <Citation citationID="ca9" URL="" title="Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders." year="2002" source="Pharmacogenomics J">
      <Xref dataSource="PubMed" identifier="12196911" />
      <Author name="Hahn MK" />
      <Author name="Blakely RD" />
    </Citation>
    <Citation citationID="b83" URL="" title="Ultrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminals." year="2003" source="J Comp Neurol">
      <Xref dataSource="PubMed" identifier="14566944" />
      <Author name="Miner LH" />
      <Author name="Schroeter S" />
      <Author name="Blakely RD" />
      <Author name="Sesack SR" />
    </Citation>
    <Citation citationID="c84" URL="" title="The functional impact of SLC6 transporter genetic variation." year="2007" source="Annu Rev Pharmacol Toxicol">
      <Xref dataSource="PubMed" identifier="17067279" />
      <Author name="Hahn MK" />
      <Author name="Blakely RD" />
    </Citation>
    <Citation citationID="b65" URL="" title="Functional coding variation in recombinant inbred mouse lines reveals multiple serotonin transporter-associated phenotypes." year="2009" source="Proc Natl Acad Sci U S A">
      <Xref dataSource="PubMed" identifier="19179283" />
      <Author name="Carneiro AM" />
      <Author name="Airey DC" />
      <Author name="Thompson B" />
      <Author name="Zhu CB" />
      <Author name="Lu L" />
      <Author name="Chesler EJ" />
      <Author name="Erikson KM" />
      <Author name="Blakely RD" />
    </Citation>
    <Citation citationID="bde" URL="" title="Going with the flow: trafficking-dependent and -independent regulation of serotonin transport." year="2008" source="Traffic">
      <Xref dataSource="PubMed" identifier="18445122" />
      <Author name="Steiner JA" />
      <Author name="Carneiro AM" />
      <Author name="Blakely RD" />
    </Citation>
    <Citation citationID="d45" URL="" title="Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans." year="2008" source="J Clin Invest">
      <Xref dataSource="PubMed" identifier="18317590" />
      <Author name="Carneiro AM" />
      <Author name="Cook EH" />
      <Author name="Murphy DL" />
      <Author name="Blakely RD" />
    </Citation>
    <Citation citationID="a69" URL="" title="Na+, Cl-, and pH dependence of the human choline transporter (hCHT) in Xenopus oocytes: the proton inactivation hypothesis of hCHT in synaptic vesicles." year="2006" source="J Neurosci">
      <Xref dataSource="PubMed" identifier="17005849" />
      <Author name="Iwamoto H" />
      <Author name="Blakely RD" />
      <Author name="De Felice LJ" />
    </Citation>
    <Citation citationID="cbf" URL="" title="Proteomic analysis of human norepinephrine transporter complexes reveals associations with protein phosphatase 2A anchoring subunit and 14-3-3 proteins." year="2005" source="Biochem Biophys Res Commun">
      <Xref dataSource="PubMed" identifier="15963952" />
      <Author name="Sung U" />
      <Author name="Jennings JL" />
      <Author name="Link AJ" />
      <Author name="Blakely RD" />
    </Citation>
    <Citation citationID="d69" URL="" title="Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase." year="2005" source="Proc Natl Acad Sci U S A">
      <Xref dataSource="PubMed" identifier="16055563" />
      <Author name="Prasad HC" />
      <Author name="Zhu CB" />
      <Author name="McCauley JL" />
      <Author name="Samuvel DJ" />
      <Author name="Ramamoorthy S" />
      <Author name="Shelton RC" />
      <Author name="Hewlett WA" />
      <Author name="Sutcliffe JS" />
      <Author name="Blakely RD" />
    </Citation>
    <Citation citationID="f47" URL="" title="Calcium-dependent interactions of the human norepinephrine transporter with syntaxin 1A." year="2007" source="Mol Cell Neurosci">
      <Xref dataSource="PubMed" identifier="17188889" />
      <Author name="Sung U" />
      <Author name="Blakely RD" />
    </Citation>
    <Citation citationID="b9f" URL="" title="Amphetamine induces a calcium/calmodulin-dependent protein kinase II-dependent reduction in norepinephrine transporter surface expression linked to changes in syntaxin 1A/transporter complexes." year="2007" source="Mol Pharmacol">
      <Xref dataSource="PubMed" identifier="17032905" />
      <Author name="Dipace C" />
      <Author name="Sung U" />
      <Author name="Binda F" />
      <Author name="Blakely RD" />
      <Author name="Galli A" />
    </Citation>
    <Citation citationID="e9b" URL="" title="Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine." year="2007" source="PLoS Biol">
      <Xref dataSource="PubMed" identifier="17941718" />
      <Author name="Williams JM" />
      <Author name="Owens WA" />
      <Author name="Turner GH" />
      <Author name="Saunders C" />
      <Author name="Dipace C" />
      <Author name="Blakely RD" />
      <Author name="France CP" />
      <Author name="Gore JC" />
      <Author name="Daws LC" />
      <Author name="Avison MJ" />
      <Author name="Galli A" />
    </Citation>
    <Citation citationID="d5e" URL="" title="Ultrastructural interactions between terminals expressing the norepinephrine transporter and dopamine neurons in the rat and monkey ventral tegmental area." year="2004" source="Synapse">
      <Xref dataSource="PubMed" identifier="15103690" />
      <Author name="Liprando LA" />
      <Author name="Miner LH" />
      <Author name="Blakely RD" />
      <Author name="Lewis DA" />
      <Author name="Sesack SR" />
    </Citation>
    <Citation citationID="cb5" URL="" title="Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation." year="2004" source="Mol Pharmacol">
      <Xref dataSource="PubMed" identifier="15155839" />
      <Author name="Zhu CB" />
      <Author name="Hewlett WA" />
      <Author name="Feoktistov I" />
      <Author name="Biaggioni I" />
      <Author name="Blakely RD" />
    </Citation>
    <Citation citationID="ad9" URL="" title="Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans." year="2008" source="J Clin Invest">
      <Xref dataSource="PubMed" identifier="18317590" />
      <Author name="Carneiro AM" />
      <Author name="Cook EH" />
      <Author name="Murphy DL" />
      <Author name="Blakely RD" />
    </Citation>
    <Citation citationID="ef9" URL="" title="Anomalous dopamine release associated with a human dopamine transporter coding variant." year="2008" source="J Neurosci">
      <Xref dataSource="PubMed" identifier="18614672" />
      <Author name="Mazei-Robison MS" />
      <Author name="Bowton E" />
      <Author name="Holy M" />
      <Author name="Schmudermaier M" />
      <Author name="Freissmuth M" />
      <Author name="Sitte HH" />
      <Author name="Galli A" />
      <Author name="Blakely RD" />
    </Citation>
  </Citations>
  <OntologyTerms>
    <OntologyTerm term="monoamine transport pathway" ontology="Pathway Ontology" ontologyTermID="PW:0001250" />
    <OntologyTerm term="regulatory pathway" ontology="Pathway Ontology" ontologyTermID="PW:0000004" />
  </OntologyTerms>
</Pathway>

